NY Times Deals New Card

Anybody who still appreciates the arcane pleasure of reading an actual newsprint newspaper knows how important it is what makes it onto the front page. The New York Times’s prominent placement of a column by personal finance columnist Ron Lieber signals an important development: traditional news organizations’ increasing willingness to level with readers and not Read More

Paying More to Cut Costs

The Washington Post today reviews the political push that led to the $36.5 billion in Obama’s stimulus package devoted to modernizing health records. Behind the president’s rosy predictions about the plan’s cost savings is the very industry that stands to gain a fortune from the bill’s passage. Candidate Obama promised $77.8 billion could be saved Read More

Investigative Story of the Week

Covering the increasingly urgent matter of food supply safety, the New York Times’s Michael Moss delivers a classic of investigative reporting in his examination of manufacturer instructions relating to frozen entrees. The thrust of the article is that, as food manufacturers look to cut costs and increase imports of ingredients, more and more pathogens are Read More

Insolvency

Anytime government or corporate interests allege an imminent crisis, journalists must guard themselves against manipulative terminology. Take the report the Obama administration released yesterday showing that the Social Security and Medicare trust funds are being depleted at a faster rate, thanks in part to the recession. The Medicare fund will run out of money in Read More

A Look Back: Hedge Funds

Sometimes, here at WhoWhatWhy, we find it useful to see what was said, back in the good old days, about the institutions that later became so reviled. Along these lines, we refer you to an April 2007 New York Magazine cover package, “Behind the Hedge”—a primer on hedge funds and the (almost all) men who Read More

Tags:

Big Pharma Pays to Publish its own "Journals"

The Scientist reports that Elsevier, the world’s leading publisher of scientific and medical texts, has taken money from Merck and other pharmaceutical companies to issue official-looking journals that subtly pushed their products. Scientific publishing giant Elsevier put out a total of six publications between 2000 and 2005 that were sponsored by unnamed pharmaceutical companies and Read More